International

Submitted by Thomas Schatz on April 16, 2025 - 17:32

President Trump's EO addresses the dual objectives of lowering drug prices while promoting innovation and protecting IP

Submitted by Thomas Schatz on April 16, 2025 - 17:32 1744839152

Amendment 50 prohibits funds from enforcing any rule or regulation that will cost the economy $100 million or more.

Congress and the White House should support America's leading and most innovative industry.

Steel tariffs have acted as an artificial tax and have resulted in higher prices of consumer goods.

Submitted by Thomas Schatz on August 2, 2022 - 12:05

The Inflation Reduction Act of 2022 will raise taxes, increase spending, and prolong both inflation and the recession.

Submitted by Thomas Schatz on August 2, 2022 - 12:05 1659456312

The TRIPS waiver would allow foreign countries to seize the IP of American innovators.

Drug importation will not only fail to lower prices but also compromise the safety of the United States healthcare system.

Policymakers around the world should continue to promote policies which strengthen intellectual property protections.

Submitted by Deborah Collier on November 30, 2021 - 11:43

Federal agencies must stop objecting to the FCC's decisions to open up spectrum for much-needed 5G deployment.

Submitted by Deborah Collier on November 30, 2021 - 11:43 1638290622

The U.S. delegation to the WHO should advocate harm reduction policies as part of an overall tobacco control strategy.